19.61
Precedente Chiudi:
$19.87
Aprire:
$19.91
Volume 24 ore:
56,844
Relative Volume:
0.35
Capitalizzazione di mercato:
$279.87M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+4.09%
1M Prestazione:
-9.71%
6M Prestazione:
+19.94%
1 anno Prestazione:
-43.16%
Neurogene Inc Stock (NGNE) Company Profile
Nome
Neurogene Inc
Settore
Industria
Telefono
(877) 237-5020
Indirizzo
535 W 24TH STREET, NEW YORK
Confronta NGNE con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NGNE
Neurogene Inc
|
19.61 | 280.30M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-17 | Iniziato | Craig Hallum | Buy |
2025-05-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
2024-06-27 | Iniziato | BMO Capital Markets | Outperform |
2024-06-11 | Iniziato | Robert W. Baird | Outperform |
2024-04-29 | Iniziato | Leerink Partners | Outperform |
2024-03-21 | Iniziato | William Blair | Outperform |
2024-01-08 | Iniziato | H.C. Wainwright | Buy |
2024-01-05 | Iniziato | Stifel | Buy |
2024-01-04 | Iniziato | TD Cowen | Outperform |
Mostra tutto
Neurogene Inc Borsa (NGNE) Ultime notizie
What is Neurogene Inc.’s valuation compared to sector2025 Key Lessons & Long-Term Growth Portfolio Plans - khodrobank.com
How to manage a losing position in Neurogene Inc.Weekly Stock Analysis & Weekly Top Gainers Trade List - Newser
How sentiment analysis helps forecast Neurogene Inc.Market Growth Review & Weekly Return Optimization Alerts - Newser
What’s the recovery path for long term holders of Neurogene Inc.July 2025 Sentiment & Stock Market Timing Techniques - Newser
Using data models to predict Neurogene Inc. stock movementQuarterly Profit Summary & High Accuracy Swing Trade Signals - Newser
Is Neurogene Inc. forming a bottoming baseJuly 2025 Decliners & Daily Stock Trend Reports - Newser
Is Neurogene Inc. stock reversal real or fakeTrade Entry Summary & Proven Capital Preservation Methods - Newser
What earnings revisions data tells us about Neurogene Inc.Weekly Stock Report & High Yield Stock Recommendations - Newser
Using Ichimoku Cloud for Neurogene Inc. technicalsMarket Risk Analysis & Scalable Portfolio Growth Methods - Newser
How institutional ownership impacts Neurogene Inc. stockPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Will Neurogene Inc. stock recover after recent dropTrade Analysis Report & Expert-Curated Trade Recommendations - Newser
Order flow analysis tools used on Neurogene Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser
Is Neurogene Inc. currently under institutional pressure2025 Winners & Losers & Fast Moving Trade Plans - khodrobank.com
Neurogene Inc. stock chart pattern explainedEarnings Growth Report & Precise Swing Trade Entry Alerts - Newser
Is Neurogene Inc. a potential multi baggerJuly 2025 Big Picture & Entry Point Strategy Guides - khodrobank.com
Chart based exit strategy for Neurogene Inc.Portfolio Value Summary & Short-Term Swing Trade Alerts - Newser
What’s the fair value of Neurogene Inc. stockSwing Trade & Community Trade Idea Sharing Platform - khodrobank.com
What technical models suggest about Neurogene Inc.’s comebackMarket Weekly Review & Weekly Momentum Picks - Newser
What momentum shifts mean for Neurogene Inc.July 2025 News Drivers & Weekly Breakout Opportunity Watchlist - Newser
Is Neurogene Inc. a play on infrastructure spendingQuarterly Investment Review & AI Based Trade Execution Alerts - khodrobank.com
What earnings revisions data tells us about Neurogene IncQuarterly Risk Review & Low Drawdown Trading Strategies - Newser
Quantitative breakdown of Neurogene Inc. recent moveLayoff News & Weekly Top Stock Performers List - Newser
Heatmap analysis for Neurogene Inc. and competitorsQuarterly Growth Report & Verified Trade Idea Suggestions - Newser
Intrinsic Value of Neurogene Inc. Stock: Is It Undervalued or Overvalued2025 Pullback Review & Long Hold Capital Preservation Tips - Newser
Will Neurogene Inc. rebound enough to break evenQuarterly Growth Report & Free Reliable Trade Execution Plans - Newser
Measuring Neurogene Inc.’s beta against major indicesWeekly Investment Report & Verified Swing Trading Watchlist - Newser
Will Neurogene Inc. Sustain Its Chart Breakout2025 Market WrapUp & Real-Time Price Movement Reports - beatles.ru
Using economic indicators to assess Neurogene Inc. potentialJuly 2025 Market Mood & Low Drawdown Momentum Ideas - Newser
Has Neurogene Inc. found a price floor2025 Market Overview & Real-Time Buy Signal Notifications - Newser
Should you hold or exit Neurogene Inc. now2025 Bull vs Bear & Safe Capital Growth Tips - Newser
Volume Profile Shows Strong Base for Neurogene Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Will Neurogene Inc. bounce back from current supportWeekly Investment Recap & Weekly Return Optimization Plans - Newser
Neurogene Inc. stock trend outlook and recovery path2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser
Neurogene Inc Azioni (NGNE) Dati Finanziari
Non sono disponibili dati finanziari per Neurogene Inc (NGNE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):